COURTNEY HARRIGAN: Open Payments
NPI 1508111303 · FEASTERVILLE TREVOSE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,235 in 64 payments from 19 companies in 2025. Trend: 2023 $592 · 2024 $895 · 2025 $1,235
Food & beverage: $1,235
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $171 |
| PFIZER INC. | 14 | $171 |
| SANOFI-AVENTIS U.S. LLC | 3 | $160 |
| ABBVIE INC. | 5 | $94 |
| Lilly USA, LLC | 4 | $88 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Axsome Therapeutics, Inc. | 3 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Amgen Inc. | 3 | $54 |
Products named: TZIELD, NURTEC ODT, VRAYLAR, AIRSUPRA, Auvelity, PREVNAR 20, CAPLYTA, MOUNJARO.
Industry payments across PA — which companies pay providers there.
